BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,910,140 | -14.9% | 315,584 | +2.8% | 0.03% | -22.0% |
| Q2 2023 | $13,991,932 | -1.9% | 307,110 | -12.7% | 0.04% | +32.3% |
| Q1 2023 | $14,267,426 | +158.7% | 351,761 | +225.1% | 0.03% | +106.7% |
| Q4 2022 | $5,514,291 | -28.9% | 108,187 | -24.9% | 0.02% | -34.8% |
| Q3 2022 | $7,756,000 | +99.6% | 143,982 | +138.0% | 0.02% | +76.9% |
| Q2 2022 | $3,886,000 | -15.1% | 60,500 | +2.5% | 0.01% | -13.3% |
| Q1 2022 | $4,575,000 | -43.5% | 59,000 | -37.5% | 0.02% | -42.3% |
| Q4 2021 | $8,103,000 | -47.7% | 94,400 | -51.0% | 0.03% | -52.7% |
| Q3 2021 | $15,486,000 | +170.6% | 192,528 | +170.8% | 0.06% | +150.0% |
| Q2 2021 | $5,723,000 | -8.9% | 71,100 | -4.6% | 0.02% | -21.4% |
| Q1 2021 | $6,284,000 | +107.4% | 74,500 | +97.2% | 0.03% | +115.4% |
| Q4 2020 | $3,030,000 | -37.1% | 37,773 | -36.9% | 0.01% | -50.0% |
| Q3 2020 | $4,818,000 | +62.7% | 59,900 | +74.1% | 0.03% | +36.8% |
| Q2 2020 | $2,962,000 | +178.6% | 34,400 | +162.6% | 0.02% | +137.5% |
| Q1 2020 | $1,063,000 | -65.2% | 13,100 | -64.2% | 0.01% | -60.0% |
| Q4 2019 | $3,058,000 | +535.8% | 36,570 | +564.9% | 0.02% | +400.0% |
| Q3 2019 | $481,000 | -81.6% | 5,500 | -82.8% | 0.00% | -81.8% |
| Q2 2019 | $2,612,000 | -35.5% | 31,900 | -35.9% | 0.02% | -29.0% |
| Q1 2019 | $4,049,000 | +30.6% | 49,800 | +5.7% | 0.03% | +34.8% |
| Q4 2018 | $3,100,000 | -52.5% | 47,100 | -44.3% | 0.02% | -32.4% |
| Q3 2018 | $6,522,000 | +9.4% | 84,592 | +4.8% | 0.03% | +6.2% |
| Q2 2018 | $5,961,000 | +17.2% | 80,732 | +3.2% | 0.03% | +10.3% |
| Q1 2018 | $5,088,000 | +15.7% | 78,229 | +14.9% | 0.03% | +38.1% |
| Q4 2017 | $4,398,000 | +115.6% | 68,100 | +109.3% | 0.02% | +133.3% |
| Q3 2017 | $2,040,000 | -41.4% | 32,533 | -43.4% | 0.01% | -57.1% |
| Q2 2017 | $3,479,000 | +58.4% | 57,500 | +35.6% | 0.02% | +40.0% |
| Q1 2017 | $2,197,000 | -37.8% | 42,400 | -46.9% | 0.02% | -37.5% |
| Q4 2016 | $3,533,000 | -5.8% | 79,800 | +1.3% | 0.02% | -4.0% |
| Q3 2016 | $3,751,000 | -19.5% | 78,800 | -23.4% | 0.02% | -19.4% |
| Q2 2016 | $4,657,000 | -33.8% | 102,881 | -39.9% | 0.03% | -50.0% |
| Q1 2016 | $7,034,000 | +204.1% | 171,300 | +182.5% | 0.06% | +181.8% |
| Q4 2015 | $2,313,000 | +38.5% | 60,635 | +19.4% | 0.02% | +37.5% |
| Q3 2015 | $1,670,000 | -76.4% | 50,800 | -49.7% | 0.02% | -77.1% |
| Q2 2015 | $7,067,000 | +83.7% | 101,000 | +79.9% | 0.07% | +79.5% |
| Q1 2015 | $3,848,000 | +24.1% | 56,139 | +32.8% | 0.04% | +39.3% |
| Q4 2014 | $3,100,000 | -31.4% | 42,283 | -32.9% | 0.03% | -48.1% |
| Q3 2014 | $4,521,000 | +56.4% | 63,000 | +57.5% | 0.05% | +38.5% |
| Q2 2014 | $2,890,000 | -52.5% | 40,000 | -51.7% | 0.04% | -55.2% |
| Q1 2014 | $6,090,000 | -39.8% | 82,800 | -43.1% | 0.09% | -10.3% |
| Q4 2013 | $10,116,000 | +85.1% | 145,400 | +74.8% | 0.10% | +67.2% |
| Q3 2013 | $5,466,000 | -25.9% | 83,189 | -21.8% | 0.06% | -17.1% |
| Q2 2013 | $7,374,000 | – | 106,400 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |